Notably, it was shown that VDR promoter methylation expression in patients with HCC was positively associated with AFP values [132]; in addition, the combined use of VDR gene promoter methylation with the AFP routinely increased its sensitivity to 93.3% [132]. This evidence concerns the gene AFP and hepatocellular carcinoma.